Saudi Journal of Oral Sciences

REVIEW ARTICLE
Year
: 2022  |  Volume : 9  |  Issue : 1  |  Page : 10--16

Mucormycosis, COVID-19, and immunosuppression – The three sides of similar triangle: Narrative review


Amit Kumar Sharma, Akshat Gupta, Vijayata Jayprakash Singh, Chetna Kishor Gabhane, Mahek Modi 
 Daswani Dental College and Research Centre, Kota, Rajasthan, India

Correspondence Address:
Dr. Vijayata Jayprakash Singh
Daswani Dental College and Research Centre, Kota - 324 005, Rajasthan
India

Introduction: More than two years into the COVID 19 pandemic, medical fraternity each day is facing renewed challenges. Mucormycosis has historically been prevalent in the various parts of world but did not had any diagnostic opportunity before the turn of 20th century. Immunosuppression in any form was always and will forever be the most important ingredients in this disease recipe. Minimally invasive diagnoses with aggressive antimicrobials in addition to the removal of immunosuppression factor are the golden standard of treatment, as oral and maxillofacial surgeons we acknowledge that surgical debridement and various other relatively newer adjunctive therapies have overall reduced the fatal outcomes for such a lethal disease. Aim: This review article focuses on gathering data in relation to immunosuppression due to whatsoever reason and pathogenesis, management, and chance of positive prognosis for patient suffering from mucormycosis . Including surgical and prosthetic options which ascertain descent quality of life for the patient. Materials and Methods: Existing data compilation including the latest research and co-relation of various types of immunosuppression as a nidus for mucormycosis, including the role of novel covid-19 from all relevant electronic databases. Results: Definite co-relation has been stablished for diabetes melitus and covid-19 and speculative co-relation for various types of malignancy and various conditions. Discussion: A strong immunity is an antagonist for mucormycosis, and new advances in field of medicine and surgery have changed the grim look of past where this disease had a 50% mortality rate. Conclusion: Existing literature supports immunosuppression in any form as a nidus for mucormycosis, still further, elaborate research and development is required for identifying the particular cocktail for different diseases process.


How to cite this article:
Sharma AK, Gupta A, Singh VJ, Gabhane CK, Modi M. Mucormycosis, COVID-19, and immunosuppression – The three sides of similar triangle: Narrative review.Saudi J Oral Sci 2022;9:10-16


How to cite this URL:
Sharma AK, Gupta A, Singh VJ, Gabhane CK, Modi M. Mucormycosis, COVID-19, and immunosuppression – The three sides of similar triangle: Narrative review. Saudi J Oral Sci [serial online] 2022 [cited 2022 Aug 15 ];9:10-16
Available from: https://www.saudijos.org/article.asp?issn=1658-6816;year=2022;volume=9;issue=1;spage=10;epage=16;aulast=Sharma;type=0